Carsten Hoffmann

Title: Carsten Hoffmann: Innovator in Seven-Transmembrane Receptor Technology

Introduction

Carsten Hoffmann is a notable inventor based in Leinach, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of innovative technologies related to seven-transmembrane receptors. His work has implications for pharmacology and molecular biology.

Latest Patents

Hoffmann holds a patent for a "Millisecond activation switch for seven-transmembrane proteins." This invention relates to recombinant seven-transmembrane receptors, where the amino terminus is positioned on the extracellular side and the carboxy-terminus on the intracellular side of a membrane. The patent describes a system that includes at least two detectable labels, with specific placements on the receptor's structure. Additionally, it outlines nucleic acid molecules encoding these receptors, as well as methods for identifying and screening compounds that can modify the biological functions of these proteins. The invention also includes diagnostic compositions and kits that utilize these compounds.

Career Highlights

Carsten Hoffmann is affiliated with Julius-Maximilians-Universität, where he continues to advance research in his field. His work has garnered attention for its potential applications in drug development and therapeutic interventions.

Collaborations

Hoffmann has collaborated with notable colleagues such as Moritz Bünemann and Jean-Pierre Vilardaga. These partnerships have contributed to the advancement of research in seven-transmembrane receptor technology.

Conclusion

Carsten Hoffmann's innovative work in the realm of seven-transmembrane receptors showcases his commitment to advancing scientific knowledge and technology. His contributions are poised to have a lasting impact on the fields of pharmacology and molecular biology.